Filing Details
- Accession Number:
- 0001104659-23-010732
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-03 18:15:45
- Reporting Period:
- 2023-01-20
- Accepted Time:
- 2023-02-03 18:15:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1836820 | Claire Poll | 3 More London Riverside London X0 SE1 2RE | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2023-01-20 | 178,800 | $0.00 | 2,211,439 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-02-01 | 152,000 | $0.00 | 2,059,439 | No | 5 | G | Direct | |
| Ordinary Shares | Acquisiton | 2023-02-01 | 152,000 | $0.00 | 926,256 | No | 5 | G | Indirect | By Trust |
| Ordinary Shares | Disposition | 2023-02-01 | 152,000 | $2.59 | 774,256 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Share Units | Disposition | 2023-01-20 | 86,272 | $0.00 | 86,272 | $0.00 |
| Ordinary Shares | Restricted Share Units | Disposition | 2023-01-20 | 34,248 | $0.00 | 34,248 | $0.00 |
| Ordinary Shares | Restricted Share Units | Disposition | 2023-01-20 | 58,280 | $0.00 | 58,280 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-04-26 | No | 4 | M | Direct | |
| 0 | 2028-03-08 | No | 4 | M | Direct | |
| 8,328 | 2029-03-29 | No | 4 | M | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
- Consists of (i) 1,820,000 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which may be represented by 227,500 ADSs); (ii) 239,432 Ordinary Shares underlying 29,929 ADSs; and (iii) 7 Ordinary Shares.
- Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.
- The sales reported in the Form 4 were effected solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
- The price reported represents the weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $2.575 to $2.6138, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Each Restricted Share Unit represents a contingent right to receive one (1) Ordinary Share of the Issuer (which may be represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer) subject to certain time- and performance-based vesting criteria.
Billionaire Hedge Funds
